Almac Discovery, a member of the Almac Group, has announced the appointment of Dr Alan Lamont to the position of vice president of BD & Licensing.
In the role, the company says that Dr Lamont will assume overall responsibility for all commercial activities within Discovery including the evaluation, structuring, negotiation and due diligence of BD and Licensing opportunities, and providing commercial input into research and discovery strategy as part of the Discovery senior management team.
He holds both a PhD in Immunology/Physiology from the Faculty of Medicine at University of Edinburgh and a BSc from Faculty of Science from University of Glasgow.
Dr Stephen Barr, managing director and president, commented on Alan’s appointment: “We are pleased to welcome Alan to our senior management team at Almac Discovery. With extensive experience in the pharma and biotech space, particularly within the BD and licensing space, his expertise, understanding and industry insight makes him the ideal choice to oversee this vital function. We very much look forward to working with him as we continue to expand globally.”